Japanese Telecom Services and Carriers Stock News

Ecowende announced that its 760MW Hollandse Kust West offshore wind farm in the Netherlands, developed by a joint venture including Chubu Electric Power, has been connected to TenneT's offshore grid and has already delivered its first green electricity. This milestone highlights Chubu Electric Power's growing participation in large-scale international renewable projects, underlining its role in the broader energy transition. With the Hollandse Kust West project now feeding power into the...

Ono Pharmaceutical (TSE:4528) moved sharply on the back of regulatory progress for Opdivo, pipeline updates around Velexbru and Qinlock, and encouraging mid stage trial data that reinforced interest in its cancer and rare disease portfolio. See our latest analysis for Ono Pharmaceutical. Against this backdrop, Ono Pharmaceutical’s share price has a 10.5% 1 month share price return and a 12.3% year to date share price return, while its 1 year total shareholder return of 65.0% points to strong...

Sales update puts Kyoritsu Maintenance in focus Kyoritsu Maintenance (TSE:9616) has drawn fresh attention after reporting preliminary sales for May 2026 and the year to date, with both figures higher than the same periods a year earlier. See our latest analysis for Kyoritsu Maintenance. The recent sales update has arrived alongside a strong run in Kyoritsu Maintenance's share price, with a 30 day share price return of 24.43% and a 90 day share price return of 22.27%. This comes even though...

Key earnings guidance figures investors are watching BANDAI NAMCO Holdings (TSE:7832) recently issued new earnings guidance, outlining expectations for the six months ending September 30, 2026, and the full fiscal year ending March 31, 2027, giving investors fresh visibility on projected results. For the first half of the fiscal year, the company is guiding to net sales of ¥610,000 million, operating profit of ¥84,000 million, profit attributable to owners of parent of ¥60,000 million, and...

Mitsubishi UFJ Financial Group has filed its annual report for the year ended March 31, 2026 and, following shareholder approval on June 26, 2026, confirmed a year-end dividend of ¥51 per share, totaling approximately ¥576.85 billion with an effective date of June 29, 2026. Together with a recently completed share repurchase of 31,967,100 shares for ¥99,999.77 million, these actions highlight the group’s current approach to shareholder returns and capital allocation. Against this backdrop,...

The start of commercial production at CG Semi’s G1 OSAT facility in Gujarat puts Renesas Electronics (TSE:6723) in focus, as investors assess what this new India based capacity could mean for the stock. See our latest analysis for Renesas Electronics. Recent trading reflects this backdrop, with Renesas Electronics’ share price at ¥4,744, a 90 day share price return of 81.69% and a 1 year total shareholder return of 152.43%, suggesting strong momentum rather than a short term spike. If you are...

EXEO Group (TSE:1951) has completed the share repurchase program announced on February 6, 2026, buying back 1,425,100 shares for ¥3,999.56 million. Recent governance votes kept the existing board lineup unchanged. See our latest analysis for EXEO Group. At a share price of ¥2,737.0, EXEO Group’s 1 year total shareholder return of 52.41% and 5 year total shareholder return of 137.34% point to strong longer term momentum, even though the 30 day share price return declined 3.30% following the...

The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even...

In July 2026, Fanatec announced a new licensing partnership with Nissan Motor to create officially licensed sim racing steering wheels that mirror Nissan’s performance driving heritage, with further product details to be shared later this year. This collaboration gives Nissan another avenue to showcase its performance brand at home, aligning with its broader push into advanced, experience-focused automotive technology. We’ll now examine how this home-based Nissan performance experience via...

Sumitomo Corp. has completed a share buyback of 33,425,200 shares, around 0.7% of its outstanding stock, for ¥57,305.75 million, and has also agreed to sell its equity stakes in three Belgian offshore wind farms: Nobelwind, Northwester 2, and Northwind. By exiting major offshore wind assets in Belgium while returning capital through buybacks, Sumitomo is materially reshaping how it allocates funds within its broader renewable and infrastructure portfolio. We’ll now examine how Sumitomo’s...

In recent weeks, ORIX Corporation completed a share buyback of 6,350,700 shares for ¥39,647.19 million, amended its Articles of Incorporation to clarify its business scope and enable virtual-only shareholder meetings, and appointed long-serving executive Satoru Matsuzaki as Representative Executive Officer, Deputy President, and Chief Operating Officer for the Japan & APAC Business Unit. Together with ORIX’s stated ambition to become a global asset manager targeting higher return on equity...

Sanrio Company recently reported full-year results for the year ended March 31, 2026, with sales of ¥194,088,000,000 and net income of ¥54,608,000,000, alongside a dividend of ¥38.00 per share for that year, up from ¥33.00 previously. The company also issued guidance for the year to March 31, 2027, pointing to higher expected sales and profit, while at the same time flagging a significantly lower dividend of ¥8.00 per share, a combination that may prompt investors to reassess how it is...

Japanese financial institutions are sitting at the crossroads of a weak yen, wide interest rate gaps with the U.S., and the possibility of government intervention in currency markets. For investors watching the Japanese yen sit near a multi decade low, this mix of forces could create both pressure and opportunity across banks and insurers. This article focuses on three Japanese Financial Institutions screener stocks that appear strongly tied to these themes, and explains how currency swings...

With global growth cooling, inflation easing in many regions and central banks keeping policy on hold, investors are increasingly looking for companies where analysts still expect healthy earnings growth and balance sheets that can handle late cycle conditions. That is exactly what the Healthy high growth potential screener aims to capture, by filtering for stocks that combine analyst expectations of strong earnings expansion over the next 3 years with acceptable financial strength. In this...

Tsubakimoto Chain (TSE:6371) has completed a share buyback program, repurchasing 2,399,000 shares, or 2.31% of its stock, for ¥6,203.81 million. This action can reshape per share metrics and ownership dynamics. See our latest analysis for Tsubakimoto Chain. Alongside the completed buyback, Tsubakimoto Chain’s share price has risen 14.06% year to date. The 1 year total shareholder return of 51.63% and 5 year total shareholder return of 188.91% point to building momentum. If this buyback has...

Mitsui O.S.K. Lines (TSE:9104) is back in focus after the board approved changes to its representative directors on June 25, 2026, including new leadership appointments and a high profile retirement. See our latest analysis for Mitsui O.S.K. Lines. The leadership reshuffle comes as Mitsui O.S.K. Lines trades at ¥5,379, with the share price up 3.58% over one day and 2.77% over seven days, but down 7.27% over 30 days and 21.70% over 90 days. Total shareholder return of 18.35% over one year and...

As global markets navigate a mix of economic signals, with the U.S. labor market showing signs of cooling and China's manufacturing sector exhibiting resilience, investors are increasingly attuned to the nuanced dynamics within Asian markets. In this context, identifying promising stocks often involves seeking companies that demonstrate robust fundamentals and adaptability in a shifting economic landscape.

Japan Tobacco (TSE:2914) has drawn fresh attention after Zacks upgraded its rating, citing an upward trend in earnings estimates that points to improving expectations around the company’s underlying business performance and investor sentiment. See our latest analysis for Japan Tobacco. The recent Zacks upgrade comes alongside steady share price gains, with Japan Tobacco’s share price showing a 9.81% year to date return and a 5 year total shareholder return of 284.09%, suggesting momentum has...

China’s latest export controls on Japanese defense and technology companies have pushed supply chain security and rare earth independence back into the spotlight. For investors, this kind of shock can quickly reshape how risk and opportunity are priced across Japanese stocks exposed to the news. This article breaks down what the policy shift might mean for larger domestic supply chain players, and why some of them could see changing expectations around their role in Japan’s push for...

DCM Holdings earnings event and what it means for investors DCM Holdings (TSE:3050) has drawn fresh attention after reporting first quarter results to May 31, 2026, with sales of ¥151,942 million and net income of ¥6,558 million, both higher than a year earlier. See our latest analysis for DCM Holdings. Despite the stronger first quarter figures, DCM Holdings’ recent share price performance has been mixed. The 1-day share price return was 1.01%, but the 90-day share price return declined...

We can readily understand why investors are attracted to unprofitable companies. For example, although...

Sompo Holdings (TSE:8630) is back in focus after the company reported progress on its open market share repurchase program, including completion of a ¥9.75b tranche. This has sharpened attention on its capital allocation plans. See our latest analysis for Sompo Holdings. The share buyback update comes after a strong run in Sompo Holdings' stock, with a 1 month share price return of 14.78% and a year to date share price return of 24.63%, alongside a 1 year total shareholder return of 65.55%...

While TOKYO KEIKI INC. ( TSE:7721 ) might not have the largest market cap around , it received a lot of attention from...

Nippon Shinyaku Co., Ltd. recently entered into an option agreement with Elixirgen Therapeutics to potentially secure exclusive worldwide rights to develop and commercialize EXG-7001, an investigational mRNA-based therapy for Duchenne muscular dystrophy that is currently in preclinical development ahead of planned U.S. trials. This move deepens Nippon Shinyaku’s rare-disease focus by targeting full-length dystrophin expression regardless of mutation type, potentially broadening the...